PathoQuest raised €15M in a Series B round in Nov 2021. The company is based in Paris, France. Investors in the round: Aurinvest, Charles River Laboratories, Eurazeo and 5 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
